This conference was developed by SAHF and is intended for UK practising healthcare professionals only. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the sponsored symposium sessions, for which the respective sponsoring companies are fully responsible. Sponsoring companies can be found at the foot of the page.
Conference Speakers:
Prof Naveed Sattar
-
Cardiovascular disease in South Asians
-
Naveed Sattar is a diabetes/metabolic medicine expert. He has been a Clarivate Analytics Global Highly Cited Researcher every year for the last decade. His research focuses on the prevention and management of diabetes, obesity and CVD. His main contributions have helped define cardiovascular risks in diabetes including the relevance of age of onset, ethnicity, and specific drugs. He has also helped improve knowledge on general CVD risk factors including lipids, and the role of obesity across many outcomes. He has published over 1500 papers, cited more than 200K times and participated in multiple guidelines and clinical trials of lifestyle interventions and novel medicines. He has been the recipient of multiple award lectures including from the European and American Diabetes Associations. He continues to serve as Associate Editor for Diabetes Care.
Dr Clare Hambling
-
An Update from the National Diabetes and Obesity Programmes
-
Dr Clare Hambling was appointed National Clinical Director for Diabetes and Obesity in January 2024. She is a General Practitioner in Norfolk and Waveney, where she has practiced for nearly 25 years. Clare has a long established interest in Diabetes, cardiometabolic health, Population Health Management and health inequalities. She is passionate about the power of data and digital transformation in clinical care. Prior to her role with NHS England, Clare had developed broad clinical leadership experience as a Governing Body GP for West Norfolk CCG and subsequently for Norfolk and Waveney CCG, and maintains a clinical leadership role with Norfolk and Waveney ICS (NWICS). She was the Chair of the Primary Care Diabetes and Obesity Society (formerly the Primary Care Diabetes Society) 2018-2024. It has been an extremely busy but exciting time since joining NHS England, with involvement across aspects of the Diabetes and Obesity programmes.
Prof Chittaranjan S Yajnik
-
Life Course Evolution of Diabetes in Indians
-
Prof. Yajnik is a diabetologist and a researcher who has made substantial contributions to the investigations of the high susceptibility of Indians to diabetes and related disorders. He is well known for his description of the ‘thin fat Indian’ and the contribution of nutritional intrauterine programming to this phenotype. He highlighted the role of vitamin B12 deficiency and deranged 1-C metabolism in the mother to these phenomena. He has initiated a pioneering randomized-controlled trial in Pune, India to improve micronutrient status of adolescents to reduce susceptibility to diabetes in the offspring.
Dr. Yajnik’s specialty is to set up multigenerational cohorts with high retention rates and collect extensive phenotypic information. He has facilitated the transfer of many research technologies to India from a wide range of collaborators from many countries and across multiple specialties. He has created a unique Biobank dating back to samples collected from 1987, spanning many cohorts and a lifecourse serial collection of blood, urine, stool and buccal smears (DNA, RNA, plasma, microbiome) in three generations in the Pune Maternal Nutrition Study.
He is a founder member, the current President of SNEHA India (Society for Natal Effects on Health in Adults) and a founder member and Trustee of the International DOHaD society (Developmental Origins of Health and Disease). He has been awarded Hellmut Mehnert award of the International Diabetes Federation (2009), David Barker Medal of the International DOHaD society (2011), Outstanding Investigator award of the World India Diabetes Foundation (2016), 41st Gopalan Oration Award, Nutrition Society of India (2017-18) and March of Dimes Agnes Higgins Award (2019).
Prof Pratik Choudhary
-
An update on technology and how it is transforming management of diabetes
-
Pratik Choudhary is a Professor and Honorary Consultant in Diabetes with a special interest in type 1 diabetes and technology. Since joining the team in 2020, he has developed a wide portfolio of research around type 1 diabetes, management of hypoglycamia and improved use of diabetes technology. His current work is based around developing a better understanding of the impact of low and high glucose levels measured by continuous glucose monitoring systems and trying to link these data with better use of electronic health records. He is also leading work looking at evaluating the benefits of diabetes technologies in people living with type 2 diabetes. He has led the development of hands on as well as online training for people with diabetes as well as care professionals to learn about how to use diabetes technologies.
Professor Choudhary is the lead for type 1 diabetes in Leicester and is also Clinical Lead for Type 1 diabetes for the Midlands. He also chairs the Secretary of State for Transports Honorary Advisory Panel for diabetes and is ex-chair of the Diabetes Technology Network - UK that works to improve access to technology for diabetes through training, education and advocacy
Dr John Dennis
-
An update on technology and how it is transforming management of diabetes
-
Prof. John Dennis is a Wellcome Trust Fellow and Associate Professor at the University of Exeter Medical School. John’s research focuses on precision medicine in type 2 diabetes. Combining evidence from electronic health records and clinical trials, he applies advanced statistical methods to discover factors altering treatment outcomes, and develop predictive models to optimise therapy choice for individual patients. In 2022 was awarded the European Association for the Study of Diabetes Rising Star award. He is a member of the UK MRC MASTERMIND type 2 diabetes precision medicine consortium, the international Precision Medicine in Diabetes initiative, and the UK Diabetes Data Science Catalyst.
This conference was developed by SAHF and is intended for UK practising healthcare professionals only. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the sponsored symposium sessions, for which the respective sponsoring companies are fully responsible.
DIAMOND SPONSOR
PLATINUM SPONSOR
GOLD SPONSOR
GOLD SPONSOR
EXHIBITOR
DELEGATE BAGS